Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ß°£´¢¸¦ È£¼ÒÇÏ´Â Àü¸³¼±ºñ´ëÁõ ȯÀÚ¿¡¼­ Loxoprofen SodiumÀÇ È¿°ú Effectiveness of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia

´ëÇѺñ´¢±â°úÇÐȸÁö 2007³â 48±Ç 2È£ p.195 ~ 198
ÀåÇõ¼ö, ¼ÕÁöö, ¹ÚöÈñ, ±èõÀÏ, ±èº´°Ç,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀåÇõ¼ö ( Chang Hyuk-Soo ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

¼ÕÁöö ( Sohn Jee-Chul ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
¹ÚöÈñ ( Park Choal-Hee ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±èõÀÏ ( Kim Chun-Il ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±èº´°Ç ( Kim Byoung-Kun ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: The effectiveness of Loxoprofen sodium, a non-steroidal anti-inflammatory drug(NSAID), on the nocturia in patients with benign prostatic hyperplasia (BPH), not responding to anticholinergics or hypnotics, as well as alpha-blockers and 5 alpha reductase inhibitors, were investigated.

Materials & Methods: Between October 2004 and June 2005, 150 BPH patients with 2 or more episodes of nocturia, despite treatments with anticholinergics or hypnotics, were enrolled in this study. Loxoprofen, 60mg/day, was orally administered prior to sleeping for 2 weeks. The number of episodes of nocturia was assessed before and after treatment according to baseline number of episodes of nocturia, age distribution, prostate volume and previous nocturia treatment.

Results: The number of nocturia episodes decreased by at least 1 in 74.7% (112/150) of patients, and decreased by 2 or more, 1 and were unchanged or increased were 48.0, 26.7 and 25.3% of patients, respectively. In baseline nocturia ¡Ã6 group, the nocturia decreased by 1 or more in 85.0%. Treatment-emergent adverse events, including gastric discomfort(12 patients, 8.0%), weak urinary stream(5 patients, 3.3%) and leg edema(2 patients, 1.3%), occurred in 19 of the 150(12.7%) patients. There were no withdrawals resulting from adverse events.

Conclusion: Loxoprofen can be effectively combined as a treatment option for patients with BPH complaining of unresolved nocturia. However, studies on the mechanism of action, long term effectiveness and adverse events of Loxoprofen are necessary. (Korean J Urol 2007;48:195-198)

Å°¿öµå

Benign prostatic hyperplasia; Nocturia; Anti-inflammatory agents; non-steroidal

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS